Research sheds light on what causes severe inflammatory bowel disease.

Published Date: 26 Apr 2023

Researchers from Cedars-Sinai have discovered a genetic variation that raises the risk of perianal Crohn's disease, the most crippling form of the condition, in susceptible individuals.

Read Full News

Latest News

Can Romiplostim Reduce Chemo Disruptions in GI Cancer?

A recent analysis assesses whether romiplostim can reduce thrombocytopenia-driven chemotherapy dose reductions, delays, and discontinuations.

Tumor Debulking Fails to Boost Survival in Metastatic CRC

Researchers evaluated whether adding tumor debulking to standard palliative systemic therapy improves survival in patients with multiorgan metastatic colorectal cancer in the ORCHESTRA trial.

Analysis-Pediatricians Win Round 1 in Vaccine Fight, but Damage Has Been Done

A federal court injunction on Monday put a check on Health Secretary Robert F. Kennedy Jr.'s rapid assault on U.S. vaccine recommendations, but months of turmoil and...

‘Failure to Thrive’ Now ‘Faltering Weight’ in Pediatrics

The World Health Organization also recommends using a z-score for diagnosing faltering weight, in addition to growth charts.

Tx Delays in CRC More Common in Urban Men, Racial Minorities

A study using data from Surveillance, Epidemiology, and End Results evaluates how sex, race, and geographic disparities affect treatment timeliness in patients with early-onset colorectal cancer.

Popular Caraway Oil for Dyspepsia: Benefit or Risk?

Caraway oil is widely used for digestive symptoms; however, strong clinical evidence supports its use in combination with peppermint oil for functional dyspepsia.

Todays Updates

Canadian Group Calls for Earlier Colorectal Cancer Screening

Modelling shows fewer cases and deaths with screening starting at age 45 years.

Triplet Therapy Improves Posttransplant Outcomes in Myeloma

A phase 3 trial examines whether carfilzomib-lenalidomide-dexamethasone maintenance therapy improves disease control compared with lenalidomide alone in patients with multiple myeloma.

Q&A: Nipple-Sparing Mastectomy After Breast Radiation

Although many surgeons avoid it, nipple-sparing mastectomy after radiation is a feasible alternative to skin-sparing mastectomy and may help preserve patients’ psychological well-being.

Todays Updates

Canadian Group Calls for Earlier Colorectal Cancer Screening

Modelling shows fewer cases and deaths with screening starting at age 45 years.

Triplet Therapy Improves Posttransplant Outcomes in Myeloma

A phase 3 trial examines whether carfilzomib-lenalidomide-dexamethasone maintenance therapy improves disease control compared with lenalidomide alone in patients with multiple myeloma.

Q&A: Nipple-Sparing Mastectomy After Breast Radiation

Although many surgeons avoid it, nipple-sparing mastectomy after radiation is a feasible alternative to skin-sparing mastectomy and may help preserve patients’ psychological well-being.

Latest News

A recent analysis assesses whether romiplostim can reduce thrombocytopenia-driven chemotherapy dose reductions, delays, and discontinuations.

Researchers evaluated whether adding tumor debulking to standard palliative systemic therapy improves survival in patients with multiorgan metastatic colorectal cancer in the ORCHESTRA trial.

A federal court injunction on Monday put a check on Health Secretary Robert F. Kennedy Jr.'s rapid assault on U.S. vaccine recommendations, but months of turmoil and...

The World Health Organization also recommends using a z-score for diagnosing faltering weight, in addition to growth charts.

A study using data from Surveillance, Epidemiology, and End Results evaluates how sex, race, and geographic disparities affect treatment timeliness in patients with early-onset colorectal cancer.

Caraway oil is widely used for digestive symptoms; however, strong clinical evidence supports its use in combination with peppermint oil for functional dyspepsia.

News All Time

Rifabutin Regimen Matches Bismuth Regimen in H pylori Rescue

Rifabutin-based triple regimen is noninferior to classical bismuth quadruple regimen as rescue treatment for Helicobacter pylori infection.

Italian Toddler Too Sick for Second Transplant, Doctors Say

An Italian toddler left clinging to life after receiving a damaged donor heart, is not well enough to undergo a second transplant, ⁠a panel of specialists ruled on Wednesday.

Guinea-Bissau Stops Vaccine Study Funded by Trump Administration

Guinea-Bissau's foreign minister has said his government has stopped a study funded by the Trump administration aiming to evaluate side effects of the life-saving hepatitis...

Barrett’s Esophagus Guidance Emphasizes Risk Stratification

Emphasis has shifted to high-quality endoscopy based on patient risk stratification.

Unraveling the Complexities of Concomitant IBD and Hepatobiliary Disease, With Natalia Nedelkopoulou, MD Natalia Nedelkopoulou, MD

Nedelkopoulou emphasizes the importance of structured and multidisciplinary transition programs for young patients with IBD and HPB disease.

Navigating Autoimmune Overlap in Celiac Disease, With Daniel Mallon, MD Daniel Mallon, MD

Mallon explains the shared risks linking celiac disease and type 1 diabetes and why early screening improves outcomes.

Navigating Opportunities and Obstacles in Gastroparesis, With Ronen Arai, MD Ronen Arai, MD

Arai breaks down key recommendations from the 2025 AGA gastroparesis guidelines and what they mean for the field at large.

Fasting-Mimicking Diet Elicits Clinical, Biochemical Response in Mild Crohn’s Disease

Fasting-Mimicking Diet Elicits Clinical, Biochemical Response in Mild Crohn’s Disease

Obefazimod As An “Exciting” Potential Treatment for Ulcerative Colitis, With Bruce Sands, MD Bruce Sands, MD

Sands explains the potential benefits of obefazimod and reviews findings from ABTECT 1 and ABTECT 2 presented at ACG 2025.

Joshua Wechsler, MD, on dupilumab's sustained efficacy in pediatric patients with EoE Joshua Wechsler, MD, MSCI

Dupilumab maintained histologic and endoscopic improvements across all pediatric age groups with EoE, according to Joshua Wechsler, MD.

Julie Khlevner, MD, AGAF, Reacts to the FDA Approval of Linaclotide for Pediatric IBS-C Julie Khlevner, MD, AGAF

Julie Khlevner, MD, AGAF, highlights that FDA approval of linaclotide provides the first pharmacologic therapy for pediatric IBS-C.

NASPGHAN: Best Practices for Celiac Disease Follow-up with Dale Lee, MD Dale Lee, MD

Dale Lee, MD, told HCPLive that regular monitoring and potential psychosocial support are important to help children with celiac disease maintain a gluten-free diet.

ANTHEM-UC: Icotrokinra Shows Sustained Efficacy in Moderate-to-Severe Ulcerative Colitis, With Vipul Jairath, MBChB, DPhil Vipul Jaraith, MBChB, DPhil

ANTHEM-UC study findings presented at ACG show efficacy, durability and safety of icotrokinra in adults with moderate-to-severe ulcerative colitis.

Rimegepant Linked to Increased Rectal Compliance, Reduced Rectal Sensation in IBS, With Ayah Matar, MD Ayah Matar, MD

Late-breaking ACG 2025 data link rimegepant to increased rectal compliance and reduced rectal sensation in IBS without constipation.

Tegoprazan NDA Seeks FDA Approval for 3 GERD Indications

Tegoprazan NDA Seeks FDA Approval for 3 GERD Indications

AGA Urges Caution Around Surgery for Refractory Constipation in Clinical Practice Update

AGA Urges Caution Around Surgery for Refractory Constipation in Clinical Practice Update

Recommended News For You

New tumor therapy approach reduces costs and side effects while increasing accessibility

Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?

The pandemic had little impact on mental health symptoms.

Women are more susceptible to the stress caused by inflation.

Traveling to Die: The Latest Form of Medical Tourism

Sydney researchers identify new tools to improve cancer diagnosis and treatment.

New BCMA-Directed Therapies Show Promise in Multiple Myeloma

Recommended Articles For You

Precision Oncology: Cancer Screening, Genetic Counseling & Hereditary Cancer Syndromes Integration 

The Mystery of Carotid Body Tumors: The Facts You Need to Know 

The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis 

A Closer Look at MCV Modules: Features, Functions, and Benefits  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Routine breast cancer screening can bring better outcomes for patients

2.

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

3.

Achieves a High Disease Control Rate in Head and Neck BCC with Vismodegib-RT Regimen.

4.

Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.

5.

According to a study, breast cancer cells work together to physically breach barriers and proliferate.

1.

A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities

2.

The Future is Now: Navigating the Precision Revolution in Oncology Treatment

3.

Innovative Bioengineering Approaches for Erectile Function Recovery After Radical Prostatectomy

4.

Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice

5.

The Predictive Power of Targeted Radionuclide Therapy in Advanced Breast Cancer

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A New Era in Managing Cancer-Associated Thrombosis

2.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

3.

Should We Use DARA Up Front As First-Line Therapy in MM? - Part II

4.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

5.

Efficient Management of First line ALK-rearranged NSCLC - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot